Wall Street analysts expect that Stryker Corporation (NYSE:SYK) will report earnings of $1.53 per share for the current fiscal quarter, according to Zacks Investment Research. Ten analysts have made estimates for Stryker Corporation’s earnings, with the highest EPS estimate coming in at $1.58 and the lowest estimate coming in at $1.52. Stryker Corporation reported earnings of $1.39 per share in the same quarter last year, which suggests a positive year over year growth rate of 10.1%. The company is expected to announce its next quarterly earnings report on Thursday, October 26th.
On average, analysts expect that Stryker Corporation will report full year earnings of $6.50 per share for the current year, with EPS estimates ranging from $6.45 to $6.54. For the next fiscal year, analysts expect that the business will report earnings of $7.13 per share, with EPS estimates ranging from $7.01 to $7.21. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side research firms that that provide coverage for Stryker Corporation.
Stryker Corporation (NYSE:SYK) last issued its earnings results on Thursday, July 27th. The medical technology company reported $1.53 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.51 by $0.02. The firm had revenue of $3.01 billion for the quarter, compared to analysts’ expectations of $2.98 billion. Stryker Corporation had a net margin of 14.22% and a return on equity of 24.26%. The firm’s revenue was up 6.1% compared to the same quarter last year. During the same quarter last year, the company earned $1.39 earnings per share.
WARNING: This piece was first published by Community Financial News and is the property of of Community Financial News. If you are reading this piece on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this piece can be accessed at https://www.com-unik.info/2017/08/19/brokerages-expect-stryker-corporation-nysesyk-will-post-earnings-of-1-53-per-share-updated.html.
In related news, insider Lonny J. Carpenter sold 5,000 shares of the company’s stock in a transaction on Friday, August 4th. The stock was sold at an average price of $146.36, for a total transaction of $731,800.00. Following the completion of the transaction, the insider now directly owns 88,207 shares in the company, valued at approximately $12,909,976.52. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, insider David Floyd sold 19,305 shares of the company’s stock in a transaction on Wednesday, July 12th. The stock was sold at an average price of $144.56, for a total value of $2,790,730.80. The disclosure for this sale can be found here. Over the last three months, insiders have sold 31,686 shares of company stock worth $4,590,562. Corporate insiders own 7.40% of the company’s stock.
Hedge funds and other institutional investors have recently modified their holdings of the company. BlackRock Inc. increased its position in shares of Stryker Corporation by 2,526.4% in the first quarter. BlackRock Inc. now owns 21,976,771 shares of the medical technology company’s stock worth $2,893,242,000 after buying an additional 21,140,000 shares during the last quarter. Vanguard Group Inc. increased its position in shares of Stryker Corporation by 5.2% in the first quarter. Vanguard Group Inc. now owns 23,421,053 shares of the medical technology company’s stock worth $3,083,382,000 after buying an additional 1,161,688 shares during the last quarter. PNC Financial Services Group Inc. increased its position in shares of Stryker Corporation by 41.9% in the first quarter. PNC Financial Services Group Inc. now owns 1,403,420 shares of the medical technology company’s stock worth $184,759,000 after buying an additional 414,715 shares during the last quarter. SG Americas Securities LLC increased its position in shares of Stryker Corporation by 600.6% in the first quarter. SG Americas Securities LLC now owns 412,340 shares of the medical technology company’s stock worth $54,285,000 after buying an additional 353,486 shares during the last quarter. Finally, Morgan Stanley increased its position in shares of Stryker Corporation by 17.9% in the first quarter. Morgan Stanley now owns 2,144,472 shares of the medical technology company’s stock worth $282,320,000 after buying an additional 325,661 shares during the last quarter. Hedge funds and other institutional investors own 73.99% of the company’s stock.
Shares of Stryker Corporation (NYSE:SYK) opened at 146.18 on Friday. The firm has a market cap of $54.68 billion, a PE ratio of 32.63 and a beta of 0.80. The company has a 50-day moving average of $142.76 and a 200 day moving average of $134.44. Stryker Corporation has a one year low of $106.48 and a one year high of $148.84.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, October 31st. Investors of record on Friday, September 29th will be given a dividend of $0.425 per share. This represents a $1.70 annualized dividend and a dividend yield of 1.16%. The ex-dividend date is Thursday, September 28th. Stryker Corporation’s dividend payout ratio is currently 37.95%.
About Stryker Corporation
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
What are top analysts saying about Stryker Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Stryker Corporation and related companies.